Who Is a Good Candidate for GLP‑1 Medications?

GLP‑1 medications are powerful tools, but they are not a one‑size‑fits‑all solution. Understanding who benefits most can help people decide whether this therapy might fit their health goals.

Here’s a clear and practical guide.

1. People with Stress-Related or Metabolic Weight Gain

Individuals who have:

• Gained weight during prolonged stress

• Tried diet and exercise with limited success

• Notice more stubborn fat around the abdomen

  
  

often benefit, because GLP‑1 therapy supports appetite regulation and metabolic balance.

2. People With Obesity or BMI Criteria

Many clinical guidelines support GLP‑1 therapy for individuals with:

• BMI ≥ 30 (obesity)

• BMI ≥ 27 with related health risk (e.g., high waist circumference)

  
  

This aligns with how weight impacts long‑term health.¹

3. People Who Struggle With Appetite and Cravings

If someone feels out of control around food, particularly carb‑heavy or sugary foods, GLP‑1 medications can help by:

• Slowing gastric emptying

• Increasing fullness

• Normalizing hunger hormones

  
  

This can make sustainable behavior change easier.²

4. Individuals Who Want Medically Supervised Support

GLP‑1 therapy is best when:

• Started with a physician

• Regularly monitored

• Combined with lifestyle coaching

  
  

This ensures correct dosing, side effect management, and long‑term strategy — especially for people with complex schedules or stressors.

Who Might Not Be a Good Fit

GLP‑1 medications are powerful, but NOT ideal for:

• People with a history of certain endocrine cancers (e.g., medullary thyroid carcinoma)

• Pregnant or breastfeeding individuals

• People with severe gastrointestinal disorders that could be worsened by slowed gastric emptying

  
  

Physician evaluation helps determine safety for each individual.³

Summary: Good Candidates Are Often

✔ Adults with stress‑related weight gain 

✔ People with obesity or elevated BMI 

✔ People with strong hunger or cravings 

✔ Those seeking physician‑supervised metabolic support

GLP‑1 therapy is not a quick fix — it’s a medically guided step in a larger health strategy.

1. Kushner, R. F., et al. “Clinical Guidelines for Obesity Management.” Obesity, 2012.

2. le Roux, C. W., et al. “Effects of GLP‑1 on Appetite and Food Intake.” Diabetologia, 2010.

3. American Association of Clinical Endocrinologists. “Guidelines for GLP‑1 Use.” 2023.